Evidence map›Paper›PMID 30418605›Full record

ArticleNucleic acids research2019

Alu insertion variants alter mRNA splicing.

Lindsay M Payer, Jared P Steranka, Daniel Ardeljan, JaNiece Walker, Kathryn C Fitzgerald, Peter A Calabresi, Thomas A Cooper, Kathleen H Burns

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. AAGGG repeat expansions triggerScience advances · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lindsay M PayerDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Jared P SterankaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Daniel ArdeljanMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
JaNiece WalkerDepartment of Biology, Xavier University of Louisiana, New Orleans, LA 70125, USA.
Kathryn C FitzgeraldDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Peter A CalabresiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Thomas A CooperDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Kathleen H BurnsDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Johns Hopkins University · USBaylor College of Medicine · USXavier University of Louisiana · US

Funding

TRAINING IN AREAS FUNDAMENTAL TO CANCER RESEARCHT32CA009110 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATUNIS, MICHAEL J., WEERARATNA, ASHANI T · 1985 to 2025
$13.1M
MOLECULAR PATHOGENESIS OF MYOTONIC DYSTROPHYR01AR045653 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 1999 to 2018
$8.3M
Imaging Neurodegeneration in Multiple SclerosisR01NS082347 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PETER A CALABRESI, Shiv Saidha · 2013 to 2026
$7.0M
TROPONIN T ALTERNATIVE SPLICING IN EMBRYONIC HEARTR01HL045565 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 1996 to 2018
$5.5M
Transcriptome processing networks in skeletal muscle: mechanisms and functionsR01AR060733 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI COOPER, THOMAS A · 2011 to 2023
$4.0M
Exonizaton of Alu Insertion PolymorphismsR01GM124531 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BURNS, KATHLEEN H, FLOREA, LILIANA D · 2017 to 2020
$1.3M
LINE-1 genotoxicity and cytotoxicity and its relevance to cancerF30CA221175 · NCI · JOHNS HOPKINS UNIVERSITY · PI ARDELJAN, DANIEL · 2017 to 2020
$150k
NCI NIH HHS F30 CA221175NCI NIH HHS T32 CA009110NHLBI NIH HHS R01 HL045565NIAMS NIH HHS R01 AR045653NIAMS NIH HHS R01 AR060733NIGMS NIH HHS R01 GM124531NINDS NIH HHS R01 NS082347
6 · The paper itself

Abstract

RNA splicing is a highly regulated process dependent on sequences near splice sites. Insertions of Alu retrotransposons can disrupt splice sites or bind splicing regulators. We hypothesized that some common inherited polymorphic Alu insertions are responsible for splicing QTLs (sQTL). We focused on intronic Alu variants mapping within 100 bp of an alternatively used exon and screened for those that alter splicing. We identify five loci, 21.7% of those assayed, where the polymorphic Alu alters splicing. While in most cases the Alu promotes exon skipping, at one locus the Alu increases exon inclusion. Of particular interest is an Alu polymorphism in the CD58 gene. Reduced CD58 expression is associated with risk for developing multiple sclerosis. We show that the Alu insertion promotes skipping of CD58 exon 3 and results in a frameshifted transcript, indicating that the Alu may be the causative variant for increased MS risk at this locus. Using RT-PCR analysis at the endogenous locus, we confirm that the Alu variant is a sQTL for CD58. In summary, altered splicing efficiency is a common functional consequence of Alu polymorphisms including at least one instance where the variant is implicated in disease risk. This work broadens our understanding of splicing regulatory sequences around exons.

Indexed as

Alternative SplicingAlu ElementsCD58 AntigensExonsGenetic VariationHumansIntronsQuantitative Trait LociRNA, MessengerRNA Splice SitesRNA SplicingCD58 AntigensRNA, MessengerRNA Splice Sites

Identifiers

PMID30418605
PMCPMC6326789
OpenAlexW2899626692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.